Decreased Diversity of the Fecal Microbiome in Recurrent Clostridium difficile–Associated Diarrhea
The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.
Abstract
Antibiotic-associated diarrhea due to Clostridium difficile (CDAD) is thought to reflect colonization of a disrupted microbial community by the pathogen. We profiled the fecal microbiota of patients with CDAD (both initial and recurrent episodes) by culture-independent phylogenetic analysis of 16S rRNA-encoding gene sequences. Compared with those from control subjects and patients with an initial episode, the fecal communities in patients with recurrent CDAD were highly variable in bacterial composition and were characterized by markedly decreased diversity. Preservation and restoration of the microbial diversity could represent novel strategies for prevention and treatment of recurrent CDAD, which is often recalcitrant to existing therapies.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Conversely, a small, open label pilot study comparing upper and lower GI routes of administration did not show any differences44”
From Update on Fecal Microbiota Transplantation 2015: Indications, Methodologies, Mechanisms, and Outlook (2015) · cites this paper as [44]
In the citing paper
“The human gut microbiota can restrict the growth of pathogens to prevent them from colonizing the intestine (‘colonization resistance’).”
From Role of the gut microbiota in nutrient competition and protection against intestinal pathogen colonization (2023) · cites this paper as [28]
In the citing paper
“Gut microbiota with high diversity have higher colonization resistance than gut microbiota with low diversity as a result of antibiotic treatment [28].”
From Role of the gut microbiota in nutrient competition and protection against intestinal pathogen colonization (2023) · cites this paper as [28]
Citations
Cites
Measuring biological diversity
(2004) · Choice Reviews Online · doi:10.5860/choice.42-1547 · Cited by 6,621
Ecological and Evolutionary Forces Shaping Microbial Diversity in the Human Intestine
Ley, R. E., Peterson, D. A., & Gordon, J. I. (2006) · Cell · doi:10.1016/j.cell.2006.02.017 · Cited by 3,358 · cited 3×
“exist in a complex symbiosis with their host [5].”
BackgroundInfluentialSchloss, P. D., & Handelsman, J. (2005) · Applied and Environmental Microbiology · doi:10.1128/aem.71.3.1501-1506.2005 · Cited by 2,501 · cited 1×
“The distance matrix was fed into DOTUR [8] to group the sequences into operational taxonomic units (OTUs), calculate ecological diversity measures (including the Shannon index [9]), and generate rarefaction curves by use of an OTU definition of 97% sequence similarity.”
MethodAntibiotic-Associated Diarrhea
Bartlett, J. G. (2002) · New England Journal of Medicine · doi:10.1056/nejmcp011603 · Cited by 1,197 · cited 1×
“Diarrhea is a common side effect of the administration of antibiotics, with Clostridium difficile being responsible for most of the severe cases of antibiotic-associated diarrhea (AAD), including the development of pseudomembranous colitis [1].”
BackgroundMcFarland, L. V. (2006) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2006.00465.x · Cited by 872 · cited 1×
“difficile antibiotics or the administration of probiotic organisms— have been tried for treatment of RCD [12, 13] [14].”
BackgroundKyne, L., Warny, M., Qamar, A., & Kelly, C. P. (2001) · The Lancet · doi:10.1016/s0140-6736(00)03592-3 · Cited by 804 · cited 1×
“difficile toxin [11].”
Breaking The Cycle: Treatment Strategies for 163 Cases of Recurrent Clostridium Difficile Disease
McFarland, L. V., Elmer, G. W., & Surawicz, C. M. (2002) · American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2002.05839.x · Cited by 724 · cited 1×
“difficile antibiotics or the administration of probiotic organisms— have been tried for treatment of RCD [12, 13] [14].”
BackgroundAas, J., Gessert, C. E., & Bakken, J. S. (2003) · Clinical Infectious Diseases · doi:10.1086/367657 · Cited by 518 · cited 1×
“individuals to patients with RCD [4, 15]—is to alter the patient’s microbiome and to restore colonization resistance.”
BackgroundBACTERIOTHERAPY FOR CHRONIC RELAPSING CLOSTRIDIUM DIFFICILE DIARRHOEA IN SIX PATIENTS
Tvede, M., & Rask-Madsen, J. (1989) · The Lancet · doi:10.1016/s0140-6736(89)92749-9 · Cited by 491
Vollaard, E. J., & Clasener, H. A. (1994) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.38.3.409 · Cited by 478 · cited 1×
“microbiota is that of “colonization resistance” [10].”
Cited by
Items 901–999 of 999
Haanperä, M. (2011) · UTUPub (University of Turku)
Fecal Bacteriotherapy for the Treatment of Recurrent Clostridium Difficile Infection in Adults
Cramer, J. (2010) · CommonKnowledge Research Repository (Pacific University Oregon)
Characterization of the Clostridium Difficile Biofilm
Laning, M. L. (2012) · Loyola eCommons (Loyola University of Chicago)
Bedeutung der normalen Darmflora für Gesundheit und Krankheitsentstehung
Gorkiewicz, G. (2009) · Journal für Kardiologie (Krause & Pachernegg GmbH)
Evaluating patient susceptibility in Clostridium difficile infection
Islam, J. (2013) · University of Brighton Repository (University of Brighton)
Flaherty, J. P., & Angarone, M. (2011) · doi:10.1002/9781444346381.ch6
Beedles, M. (2015) · CommonKnowledge Research Repository (Pacific University Oregon)
Hoostal, M. J. (2013) · ScholarWorks@BGSU (Bowling Green State University)
Fanos, V., & Cuzzolin, L. (2014) · Molecular and integrative toxicology · doi:10.1007/978-1-4471-6539-2_7 · Cited by 1
Wang, D. (2014) · Deep Blue (University of Michigan)
Specific features of clostridium difficile colitis in patients with inflammatory bowel disease
Mihai, C., Ștefănescu, G., Gogălniceanu, P., Anton, C., Dranga, M., Jigaranu, O., Balmuș, I.-M., Timofte, D. V., Ciobica, A. S., & Prelipcean, C. (2014) · Archives of Biological Sciences · doi:10.2298/abs140915017m
“Treatment of recurring infections Recurrent infections may be possible due to immune response changes and/or GIF changes (Chang et al., 2008).”
BackgroundRzekomobłoniaste zapalenie jelit u dzieci
Mielniczuk, K., & Czerwionka‐Szaflarska, M. (2014) · Pediatria Polska · doi:10.1016/j.pepo.2014.12.001
Understanding New Concepts: Clostridium difficile Infection in Pouch Patients
Gurvits, G. E. (2014) · Digestive Diseases and Sciences · doi:10.1007/s10620-014-3112-8
“Continued use of antibiotics remains the largest risk factor for its recurrence [9] and recent data suggests that decreased overall diversity of the microbiota of the gut was associated with increased risk of subsequent bout of CDI [10].”
BackgroundClostridium difficile infection: Emerging concepts and treatments
Mathew, T., & Higginbottom, P. A. (2008) · Current Gastroenterology Reports · doi:10.1007/s11894-008-0076-x
Current advances related to Clostridium difficile infection
Jang, B.-I., & Kim, Y. (2015) · The Indian Journal of Medical Research · doi:10.4103/0971-5916.155545
Microbiota-Mediated Control of Enteric Pathogens
Yurist‐Doutsch, S., Arrieta, M., Vogt, S. L., & Finlay, B. B. (2014)
Walk, S. T., & Young, V. B. (2008)
Self-citationPackey, C. D. (2014) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.13140/rg.2.2.22562.63686
New Treatment Option for RecurrentClostridium difficileInfection
Moon, C. M. (2013) · Intestinal Research · doi:10.5217/ir.2013.11.2.149
“difficile에 대해서 저항성을 부여하는 정상 장세균총을 변경시키는 문제가 있다.(2) 성공적인 초기 치료에도 항생제 중단 이후 35% 이상의 환자들이 재발을 경험하게 되며, 재발하는 C.”
Efficacy of fecal microbiota transplantation in patients with Crohn's disease
Mallard, C. A. (2015) · OpenBU (Boston University)
Vading, M. (2016) · Figshare
Schroeter, K. (2014) · The Atrium (University of Guelph) · Cited by 2
Inhibition of NHE3 and microbiota profile
Engevik, M. A., Engevik, K. A., Yacyshyn, M. B., Wang, J., Hassett, D. J., Darien, B. J., Yacyshyn, B., & Worrell, R. T. (2014)
Indications for Surgery in Patients with Severe Clostridium Difficile Colitis
Reddy, V. B., & Longo, W. E. (2017) · Difficult decisions in surgery: an evidence-based approach · doi:10.1007/978-3-319-40223-9_25
Drug Targeting of the Human Microbiome
Ling, H., Foo, J. L., Saxena, G., Swarup, S., & Chang, M. W. (2017) · Wiley eBooks · doi:10.1002/9783527696130.ch7 · Cited by 1
The Role of the Gut Microbiota in Colonization Resistance against Clostridium difficile.
Schubert, A. M. (2015) · Deep Blue (University of Michigan)
McQuade, E. T. R. (2015) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/bz63-vs75
Transplantatie van fecale microbiota : oude wijn in nieuwe zakken?
Holvoet, T., de Wiele, T. V., Boelens, J., Raes, J., Hindryckx, P., Vos, M. D., & Looze, D. A. D. (2014) · Ghent University Academic Bibliography (Ghent University)
CLOSTRIDIUM DIFFICILE INFECTION: RISK FACTORS, DIAGNOSIS AND CONTROL
Koleci, X., & Janvilisri, T. (2012) · Albanian journal of agricultural sciences
Incidence of and risk factors for community-associated Clostridium difficile infection
Kuntz, J. L. (2010) · doi:10.17077/etd.tbm6ui0e
“difficile treatment), extended hospital stays, and concomitant therapy with antacid medications (174, 175).”
Silverman, M., Davis, I. R., & Pillai, D. R. (2010)
Ober, R. A. (2017) · K-State Research Exchange (Kansas State University)
Lee, T. W. T. (2011) · ERA: Education and Research Archive (University of Alberta) · doi:10.7939/r3w04f
MECHANISMS OF COLONIZATION RESISTANCE TO SHIGELLA FLEXNERI
Kottwitz, H. (2018) · DalSpace (Dalhousie University)
The microbiome and Clostridium difficile infection
Chiu, C. Y., & Pillai, D. R. (2013) · doi:10.2217/ebo.13.324
Factors associated with the post-operative recurrence of Crohn's disease
Laffin, M. (2018) · ERA: Education and Research Archive (University of Alberta) · doi:10.7939/r3rn30p5r
A Mechanism of Antimicrobial Resistance and a Mitigation Strategy
Bulow, C. (2018) · Open Scholarship Institutional Repository (Washington University in St. Louis) · doi:10.7936/5vzy-r748
Prevalence of infections with Clostridium difficile on potential pathology groups
Tache, T., Chirică, R., Radu, M.-D., Gegiu, G., & Rugină, S. (2019) · Analele Universităţii "Ovidius" Constanţa. Seria Chimie/"Ovidius" University Annals of Chemistry · doi:10.2478/auoc-2019-0004
Yumoto, H., Uebanso, T., Shimohata, T., & Takahashi, A. (2019) · Current Oral Health Reports · doi:10.1007/s40496-019-0221-7 · Cited by 1
The microbiota and infectious diseases
Surana, N. K. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-801496-7.00023-x · Cited by 1
Clostridium (Now Clostridioides) difficile-Associated Disease
Hays, R. A., & Surawicz, C. M. (2019) · Springer eBooks · doi:10.1007/978-3-319-90761-1_71-1
Assaying the Microbiome During Critical Illness
Bansal, S. (2018) · TSpace (University of Toronto)
Goethel, A. (2017) · TSpace (University of Toronto)
Jiang, T. (2020) · International Conference on I-SMAC (IoT in Social, Mobile, Analytics and Cloud) (I-SMAC) · doi:10.1109/i-smac49090.2020.9243312
“The interactions between C. diff and intestinal epithelial trigger the inflammatory process, causing intestinal disease such as diarrhea (Chang et al., 2008).”
BackgroundAlternative Strategies in the Treatment of Clostridioides difficile Infection
Au, R. (2021) · Asian Journal of Medicine and Health · doi:10.9734/ajmah/2021/v19i430320
“Research has shown that the microbiome diversity is decreased in the gut of patients with CDAD [28].”
BackgroundGut Microbial Dysbiosis and HIV Infection
do Nascimento, W. M., Machiavelli, A., Ferreira, F. A., Sincero, T. C. M., Zárate-Bladés, C. R., & Pinto, A. R. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-819265-8.00054-1 · Cited by 1
Reducing drug resistance should be the aim of therapies
Gupta, P. D. (2021) · Clinical Research and Clinical Trials · doi:10.31579/2693-4779/028
Moreau, G. B., Ozbek, H., Kumar, P., Frisbee, A. L., Leslie, J. L., & Petri, W. A. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.07.23.453497
“The FMT donor group was composed primarily of members of the Firmicutes phylum, with the Bacteroidota phylum making up a minor proportion (Figure 2C) The Firmicutes phylum was a smaller proportion of the antibiotic-treated vehicle control samples relative to the FMT donor group, with antibiotic-treated mice having rel…”
BackgroundInfluentialBhute, S. S., Mefferd, C. C., Phan, J. R., Ahmed, M., Fox-King, A. E., Alarcia, S., Villarama, J. V., Abel‐Santos, E., & Hedlund, B. P. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.10.04.463142
Sommermeyer, H., & Piątek, J. (2021) · Springer eBooks · doi:10.1007/978-3-030-81100-6_5
Bhat, A. M., Soodan, J. S., & Singh, R. (2022) · Veterinarski arhiv · doi:10.24099/vet.arhiv.1124
“The indiscriminate use of blanket dry cow therapy in farm animals is often associated with the development of antimicrobial resistance and dissemination (CHANG et al., 2008).”
BackgroundFind a little help from my (microbial) friends
Severyn, C. J. (2022) · Cell Host & Microbe · doi:10.1016/j.chom.2022.03.024
Control of Clostridium difficile Infection by Defined Microbial Communities
Collins, J., & Auchtung, J. M. (2018) · ASM Press eBooks · doi:10.1128/9781555819705.ch11 · Cited by 1
Torday, J. S., & Miller, W. B. (2020) · Springer eBooks · doi:10.1007/978-3-030-38133-2_12
Dupont, A. W., & Khurana, S. (2020) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.734083551.793579200
den Abbeele, P. V., Verstraete, W., Aidy, S. E., Geirnaert, A., & de Wiele, T. V. (2014) · Apple Academic Press eBooks · doi:10.1201/b17254-17 · Cited by 1
Antibiotic-Associated Diarrhea
Theriot, C. M., & Young, V. B. (2015) · Springer eBooks · doi:10.1007/978-1-4899-7475-4_64
Self-citationEnterotoxic Clostridia: Clostridioides difficile Infections
Mileto, S. J., Das, A., & Lyras, D. (2019) · ASM Press eBooks · doi:10.1128/9781683670131.ch61
Correlation of Clinical Severity With Stool Microbiome Changes in Clostridioides difficile Infection
Castañeda-Mogollón, D., Doolan, C., Toppings, N. B., Amarasekara, R., Tran, T.-A., & Pillai, D. R. (2022) · Archives of Pathology & Laboratory Medicine · doi:10.5858/arpa.2021-0636-oa · Cited by 1
Frost, F. (2023) · Journal für Gynäkologische Endokrinologie/Schweiz · doi:10.1007/s41975-023-00283-1
Clostridioides difficile Infection: Targeting an Unwelcome and Persistent Threat
Moir, H. (2023) · EMJ Microbiology & Infectious Diseases · doi:10.33590/emjmicrobiolinfectdis/10301279
Molecular Cartography of a Hawaiian Coral Assemblage
Nakoa, J. W. P., Burns, J. H. R., Steward, K., Kapono, L., & Kapono, C. A. (2023) · Diversity · doi:10.3390/d15101061
Tang, Z.-W., Zhang, C.-E., Ma, F.-Z., Cui, Y.-T., Ye, R.-H., Pu, S.-B., & Ma, Z. (2023) · SSRN Electronic Journal · doi:10.2139/ssrn.4632823
Li, Q., Wang, C., Tang, C. X., He, Q. S., Zhao, X., Li, N., & Li, J. (2021) · Figshare · doi:10.6084/m9.figshare.15095080
Microbial analyses of infectious keloids on the anterior chest—a case–control study
Chen, Q., Hou, S., Wu, X., Bu, W.-B., Zhou, B.-R., & Chen, X.-D. (2025) · Archives of Dermatological Research · doi:10.1007/s00403-024-03731-5
“Notably, the infectious group exhibited a significantly higher number of microorganisms compared to what is typically observed in the gut microbiome—a high diversity environment where reduced diversity often signals disease [17].”
Čivljak, R., & Mihanović, M. P. (2024) · Clinical gastroenterology · doi:10.1007/978-3-031-69800-2_19
Jones, D. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.03.20.644477
“It seems that drugs have a big effect on the pathophysiology of C. difficile because they lower the numbers of Firmicutes phyla and Bacteroides [7].”
Kao, D. H., Wong, K., Lee, C., Steiner, T. S., Franz, R., McDougall, C., Silva, M., Schmidt, T., Walter, J., Löebenberg, R., et al. (2025) · SSRN Electronic Journal · doi:10.2139/ssrn.5216159
Self-citationCrews, J. D. (2025) · Elsevier eBooks · doi:10.1016/b978-0-323-82763-8.00259-4
Characterization of the Human Microbiome in Health and Disease
Tan, C. Y., & Surana, N. K. (2025) · Wiley eBooks · doi:10.1002/9781683674597.ch7
Making Sense of Differing Guidelines for Clostridioides difficile Infection
Sehgal, K., Feuerstadt, P., & Wilcox, M. H. (2025) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2025.07.010
Unravelling three-way interactions between Clostridioides difficile, microbiota and the host
Bywater-Brenna, K. K., & Unnikrishnan, M. (2025) · Journal of Medical Microbiology · doi:10.1099/jmm.0.002067
“…associated with increased colonization resistance and the microbiota circumvents infection via a range of mechanisms such as nutrient and space competition, short-chain fatty acid (SCFA) production, bile salt metabolism, antimicrobial compound production and immune modulation of the host [29, 30].”
Chen, C., Pillonel, T., Carrara, A., Schaer, J., Resch, G., Galpérine, T., Guery, B. P., & Bertelli, C. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.10.09.681403
Ettinger, G. (2014) · Scholarship@Western (Western University)
Lohuis, M. A. M. (2014) · Utrecht University Repository (Utrecht University)
Grahn, J. (2014) · KTH Publication Database DiVA (KTH Royal Institute of Technology)
Li, Q., Wang, C., Tang, C., He, Q., Zhao, X., Li, N., & Li, J. (2021) · Figshare · doi:10.6084/m9.figshare.15095071
Li, Q., Wang, C., Tang, C., He, Q., Zhao, X., Li, N., & Li, J. (2021) · Figshare · doi:10.6084/m9.figshare.15095068
van Rossen, T. M., van Beurden, Y. H., Bogaards, J. A., Budding, A. E., Mulder, C. J. J., & Vandenbroucke‐Grauls, C. M. J. E. (2024) · Figshare · doi:10.6084/m9.figshare.26241262
Li, Q., Wang, C., Tang, C., He, Q., Zhao, X., Li, N., & Li, J. (2021) · Figshare · doi:10.6084/m9.figshare.15095077
Li, Q., Wang, C., Tang, C., He, Q., Zhao, X., Li, N., & Li, J. (2021) · Figshare · doi:10.6084/m9.figshare.15095062
Li, Q., Wang, C., Tang, C., He, Q., Zhao, X., Li, N., & Li, J. (2021) · Figshare · doi:10.6084/m9.figshare.15095065
Men, Y., Yue, L., Zhang, M., Wang, B., & Ying, W. (2026) · Frontiers in Nutrition · doi:10.3389/fnut.2025.1718745 · Cited by 1
Wang, W., Lu, S., Fu, Y., Yao, Y., & Hu, W. (2026) · BMC Pregnancy and Childbirth · doi:10.1186/s12884-026-08677-2
“A significant reduction in microbiome diversity has also been observed in the feces of patients with Clostridioides difficile infection [25].”
Kurmaev, D. P., Bulgakova, S. V., Treneva, E. V., Косарева, О. В., Merzlova, P. Y., Sharonova, L. A., & Dolgikh, Y. A. (2025) · Экспериментальная и клиническая гастроэнтерология · doi:10.31146/1682-8658-ecg-235-3-299-313
Méthodes d'analyse et variations du microbiote digestif
Dubourg, G. (2016) · theses.fr (ABES) · doi:10.70675/a958bd08zd303z4991z9bf9zd61ee389d83b
Analyse fonctionnelle des N-déacétylases de Clostridium difficile
Coullon, H. (2018) · theses.fr (ABES) · doi:10.70675/22601f10za273z4c0dzbeb2z5def29cbb1de · Cited by 2
Kobeissy, H. (2018) · theses.fr (ABES) · doi:10.70675/f14d613cz28dfz470aza7a6zdbe81a631560 · Cited by 1
Doan, T. H. D. (2020) · theses.fr (ABES) · doi:10.70675/f842f385z89cfz4afdz9ba7zc78309527e61
Couturier, J. (2020) · theses.fr (ABES) · doi:10.70675/fe4590c9z9e1bz4fdez88fcz8e8c0a9023e4 · Cited by 1
The role of non-coding RNAs (ncRNA) in the pathogenesis of Clostridioides difficile
Piattelli, E. (2023) · theses.fr (ABES) · doi:10.70675/430fbe25ze30az4c99z8defz8d76a374d4c5
Metadata
- Authors
- Chang, J. Y., Antonopoulos, D. A., Kalra, A., Tonelli, A., Khalife, W. T., Schmidt, T. M., & Young, V. B.
- Affiliations
- Michigan State University (US)
- Corresponding author
- Young, Vincent B.
- Venue
- The Journal of Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2008-02
- Volume
- 197
- Issue
- 3
- Pages
- 435-438
- ISSN
- 0022-1899 (ISSN-L)
- 1537-6613
- OpenAlex
- W2139607253
- Cited by
- 1,010
- References
- 15
- Citations by year
- 2026: 15 · 2025: 28 · 2024: 36 · 2023: 54 · 2022: 42 · 2021: 57 · 2020: 69 · 2019: 59 · 2018: 107 · 2017: 78 · 2016: 77 · 2015: 88 · 2014: 87 · 2013: 78 · 2012: 53
- FWCI
- 17.27
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Infectious Diseases (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Clostridium difficile and Clostridium perfringens research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Microbiology (medical) › Bacterial Identification and Susceptibility Testing
- Keywords
- Clostridium difficile, fecal microbiota, microbial diversity, antibiotic-associated diarrhea, 16S rRNA gene sequencing, bacterial community composition, dysbiosis, microbiota restoration
- MeSH terms
- Anti-Bacterial Agents, Diarrhea, Drug Administration Schedule, Enterocolitis, Pseudomembranous, Feces, Female, Humans, Male, Phylogeny, Recurrence, Reference Values, Genetic Variation, Clostridioides difficile
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.